Owner Asterand UK Limited

Inventors Clark, David Edward; Fenton, Garry; Newton, Christoper Gregory; Sutton, Jonathan Mark; Harris, Neil Victor; Davis, Richard Jon; Coleman, Robert Alexander; Stuttle, Keith Alfred James; Clark, Kenneth Lyle; Hynd, George; Oxford, Alexander William

Agent Shelston IP

Pub. Number AU-B-2004207675

PCT Pub. Number WO2004/067524

Priority 0302094.8 29.01.03 GB; 60/509,521 09.10.03 US; 60/443,872 31.01.03 US

Filing date 29 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 20 May 2010

C07D 307/54 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 411/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms